No elevated plasma catecholamine levels during sleep in newly diagnosed, untreated hypertensives

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Rasch, Björn ^a,b   Dodt, Christoph ^a,c   Sayk, Friedhelm ^a   Mölle, Matthias ^a   Born, Jan ^a,d  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c KLINIKUM BOGENHAUSEN   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ADULT; AROUSAL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART RATE; HUMAN; HYPERTENSION; MALE; NORADRENALIN BLOOD LEVEL; SLEEP STAGE; SLEEP TIME; SYSTOLIC BLOOD PRESSURE; WAKEFULNESS; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; SLEEP; TIME;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; EPINEPHRINE; HEART RATE; HUMANS; HYPERTENSION; MALE; NOREPINEPHRINE; SLEEP; SLEEP STAGES; TIME FACTORS; WAKEFULNESS;

EID: 79959238504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021292     Document Type: Article

References (22)

1. Grassi G, Seravalle G, Quarti-Trevano F, (2010) The neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol 95: 581-586.
2. Goldstein DS, Lake CR, Chernow B, Ziegler MG, Coleman MD, et al. (1983) Age-dependence of hypertensive-normotensive differences in plasma norepinephrine. Hypertension 5: 100-104.
3. Anderson EA, Sinkey CA, Lawton WJ, Mark AL, (1989) Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 14: 177-183.
4. Grassi G, (2007) Adrenergic overdrive as the link among hypertension, obesity, and impaired thermogenesis: lights and shadows. Hypertension 49: 5-6.
5. Sayk F, Becker C, Teckentrup C, Fehm HL, Struck J, et al. (2007) To dip or not to dip: on the physiology of blood pressure decrease during nocturnal sleep in healthy humans. Hypertension 49: 1070-1076.
6. Carrington MJ, Trinder J, (2008) Blood pressure and heart rate during continuous experimental sleep fragmentation in healthy adults. Sleep 31: 1701-1712.
7. Carrington MJ, Barbieri R, Colrain IM, Crowley KE, Kim Y, et al. (2005) Changes in cardiovascular function during the sleep onset period in young adults. J Appl Physiol 98: 468-476.
8. Lombardi F, Parati G, (2000) An update on: cardiovascular and respiratory changes during sleep in normal and hypertensive subjects. Cardiovasc Res 45: 200-211.
9. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, et al. (2006) Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 47: 833-839.
10. Knutson KL, Van CE, Rathouz PJ, Yan LL, Hulley SB, et al. (2009) Association between sleep and blood pressure in midlife: the CARDIA sleep study. Arch Intern Med 169: 1055-1061.
11. Friedman O, Logan AG, (2009) The price of obstructive sleep apnea-hypopnea: hypertension and other ill effects. Am J Hypertens 22: 474-483.
12. Meerlo P, Sgoifo A, Suchecki D, (2008) Restricted and disrupted sleep: effects on autonomic function, neuroendocrine stress systems and stress responsivity. Sleep Med Rev 12: 197-210.
13. Jones CR, Taylor K, Poston L, Shennan AH, (2001) Validation of the Welch Allyn 'Vital Signs' oscillometric blood pressure monitor. J Hum Hypertens 15: 191-195.
14. Rasch B, Dodt C, Molle M, Born J, (2007) Sleep-stage-specific regulation of plasma catecholamine concentration. Psychoneuroendocrinology 32: 884-891.
15. Born J, Spath-Schwalbe E, Schwakenhofer H, Kern W, Fehm HL, (1989) Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man. J Clin Endocrinol Metab 68: 904-911.
16. Rechtschaffen A, Kales A, (1968) A Manual of Standardized Terminology,Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles Brain Inf.Service, Univ. of California.
17. Goldstein DS, Feuerstein G, Izzo JL Jr, Kopin IJ, Keiser HR, (1981) Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 28: 467-475.
18. Faul F, Erdfelder E, Lang AG, Buchner A, (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39: 175-191.
19. Dodt C, Breckling U, Derad I, Fehm HL, Born J, (1997) Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 30: 71-76.
20. Goldstein DS, (1983) Plasma catecholamines and essential hypertension. An analytical review. Hypertension 5: 86-99.
21. Grassi G, (1998) Role of the sympathetic nervous system in human hypertension. J Hypertens 16: 1979-1987.
22. Lambert GW, (2000) Central nervous system norepinephrine metabolism in hypertension. Curr Hypertens Rep 2: 302-310.